ÂÜÀòÂÒÂ×

Sean Kearney is the current Chief Financial Officer at Genomenon. Prior to this, they were with Tau Ventures where they were responsible for creating a corporate venture program in partnership with a private investment platform based in Shanghai. Sean also has experience working with Cohero Health and CirrusMD Inc. as a member of their respective board of directors.

Sean Kearney has a Bachelor of Science in Finance from Miami University and an MBA in Finance from The Ohio State University - The Max M. Fisher College of Business. Sean also has certification from FINRA in Series 66 and Series 7.

Their manager is Mike Klein, CEO. Some of their coworkers include Candace Chapman - VP, Marketing, Mark J. Kiel - Chief Science Officer & Co-Founder, and Steve Schwartz - CTO & Co-Founder.